Regent Pacific Group Limited (HKG:0575)
Hong Kong
· Delayed Price · Currency is HKD 0.600
-0.020 (-3.23%)
Apr 29, 2026, 4:08 PM HKT
Regent Pacific Group Revenue
In the year 2025, Regent Pacific Group had annual revenue of $363.00K USD, down -49.51%. Regent Pacific Group had revenue of $126.00K in the half year ending December 31, 2025, with 1,475.00% growth.
Revenue
$363.00K
Revenue Growth
-49.51%
P/S Ratio
61.97
Revenue / Employee
$22.69K
Employees
16
Market Cap
175.09M HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 363.00K | -356.00K | -49.51% |
| Dec 31, 2024 | 719.00K | 428.00K | 147.08% |
| Dec 31, 2023 | 291.00K | 177.00K | 155.26% |
| Dec 31, 2022 | 114.00K | -3.14M | -96.50% |
| Dec 31, 2021 | 3.25M | 1.58M | 94.85% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Joyzyme Group | 31.47M |
| PuraPharm Corporation | 336.11M |
| Kontafarma China Holdings | 914.71M |
| Tianda Pharmaceuticals | 322.95M |
| Extrawell Pharmaceutical Holdings | 52.65M |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.08B |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Qianhai Health Holdings | 677.12M |